In a mouse model bearing subcutaneous TC-1 lung tumor, this combined therapy resulted in tumor eradication in 60% of treated mice, which could be attributed to the enhanced function of CD8+ T cell, reduced ratio of Treg/CD4+ cell and the regulation to MDSCs (111). Here, CD8A is linked to neoplasm.